Guardant Health

$118.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$6.02 (+5.34%) Today
$0.00 (0.00%) As of 6:28 AM EST after-hours

Why Robinhood?

You can buy or sell GH and other stocks, options, and ETFs commission-free!

About GH

Guardant Health, Inc. Common Stock, also called Guardant Health, is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA. The listed name for GH is Guardant Health, Inc. Common Stock.

CEO
Helmy Eltoukhy
Employees
622
Headquarters
Redwood City, California
Founded
2012
Market Cap
11.86B
Price-Earnings Ratio
Dividend Yield
Average Volume
1.36M
High Today
$118.88
Low Today
$113.12
Open Price
$113.77
Volume
388.04K
52 Week High
$122.31
52 Week Low
$55.90

Collections

GH Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 22, After Hours

You May Also Like